Overview


According to FutureWise analysis the market for Non Invasive Glucose Monitor is expected to reach US$ 0.35 billion by 2031 at a CAGR of 8.80%.

A non-invasive glucose monitor is a medical device that measures blood glucose levels without the need for a needle stick or blood sample. This is particularly important for individuals who need to monitor their blood glucose levels regularly, such as those with diabetes. Traditional glucose monitoring methods involve pricking the finger to draw blood, which can be painful and inconvenient. Non-invasive glucose monitoring devices aim to provide a more comfortable and convenient alternative. A patient's glucose levels can be continuously and painlessly monitored with non-invasive glucose monitors. Data may be simply shared and copied to the device for additional analysis. Patients can keep an eye on their blood sugar levels at home by the help of these devices. The treatment of diabetes can be greatly improved with non-invasive glucose monitoring.

There are several methods that have been explored for non-invasive glucose monitoring, including optical methods, thermal methods, acoustic methods, and electrical methods. There are several non-invasive glucose monitoring devices available on the market. For example, the FreeStyle Libre uses a small sensor placed on the skin to measure glucose levels. This sensor uses a tiny filament that penetrates the skin to measure interstitial fluid glucose levels, which provides an indirect measurement of blood glucose levels. Other devices use similar techniques, such as using light or electrical currents to measure glucose levels.

FutureWise Market Research has published a report that provides an insightful analysis of Non-Invasive Glucose Monitor Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Non-Invasive Glucose Monitor Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Google
  • Abbott Diabetes Care
  • Medtronic
  • Apple
  • Alertgy
  • Integrity Applications
  • Senseonics
  • NovioSense BV
  • Nemaura Medical
  • GENEXO
  • Ambrosia Systems Inc.
  • Glucology
  • Sano Intelligence
  • Biolinq
  • Echo Therapeutics

Recent developments by key players in Non-Invasive Glucose Monitor Market:

  • The Eversense XL distribution channel, which operates in Germany, Spain, Italy, the Netherlands, and Switzerland, was acquired by Ascensia Diabetes Care Holding AG in February 2021 in order to meet the growing demand in the European market.
  • The Accu-Chek instant, which easily connects with the mySugr app, was launched by F. Hoffmann-La Roche Corporation in March 2021. Real-time data for non-invasive blood glucose monitoring is provided by this app.

The market for non-invasive glucose monitors has been expanding due to the rising prevalence of diabetes and the need for easy-to-use glucose monitoring devices. Non-invasive glucose monitors evaluate blood glucose levels without the use of needles or lancets by utilising a range of technologies, such as optical, electrical, and thermal sensors. The increasing number of patients with diabetes in the globe is one of the major factors driving the non-invasive glucose monitor market. By 2045, the International Diabetes Federation projects that there will be 700 million individuals worldwide who have diabetes. Due to this, there is now a higher need for non-invasive glucose monitors, which can offer easy and painless glucose monitoring solutions. Technology advancements have also prompted the creation of non-invasive glucose monitors that are more accurate and dependable. These devices transform sensor data into glucose readings using advanced algorithms, and many include Bluetooth or Wi-Fi connectivity, making it simple for patients to share their data with healthcare professionals.

Despite the market for non-invasive glucose monitors having a bright future, there are still obstacles to be solved. The use of non-invasive glucose monitors in clinical settings, for instance, may be constrained by some of these devices' lower accuracy when compared to conventional glucose monitors. The expensive price of various gadgets may also prevent their widespread use, especially in low-income nations.

By Component

  • Measuring Device
  • Monitoring Patches
  • Fabric Patches
  • Herbal Patches
  • Continuous Monitoring Sensors
  • Smart Lenses
  • Smart Watches
  • Transmitter
  • Software

By Site

  • Arm/ Wrist
  • Ear Lobe
  • Forefinger and Thumb
  • Cornea/ Eye

By Application

  • Intensive Insulin Therapy
  • Hypoglycemia
  • Diabetic Foot Ulcer Tracking

By End-User

  • Home Healthcare Setting
  • Healthcare Provider
  • Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. An important reason that has contributed to North America's dominance in the market and is expected to continue in the future is the vast number of people who suffer from non-invasive blood glucose disorders and diabetes in this region. Due to the large number of international corporations that require extended working hours and the developed status of the nation, inactive lifestyle practises have greatly increased. Therefore, it has been determined that an increase in tension and lifestyle disorders are the root causes of diabetes and other blood glucose-related disorders. Due to the high levels of discretionary income in this region, there has been a significant increase in the demand for non-invasive blood glucose tracking devices.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Non Invasive Glucose Monitor Market By Component, By Technology, By Site, By Application, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customisation offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Non Invasive Glucose Monitor Market Variables, Trends and Scope
    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Non Invasive Glucose Monitor Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Non Invasive Glucose Monitor Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Non Invasive Glucose Monitor Market, By Component Historical Analysis and Forecast 2023-2031 (USD Million)
    •        1. Measuring Device
             2. Monitoring Patches
             3. Fabric Patches
             4. Herbal Patches
             5. Continuous Monitoring Sensors
             6. Smart Lenses
             7. Smart Watches
             8. Transmitter
             9. Software

  • 8.   Non Invasive Glucose Monitor Market, By Site Historical Analysis and Forecast 2023-2031 (USD Million)
    •       1. Arm/ Wrist
            2. Ear Lobe
            3. Forefinger and Thumb
            4. Cornea/ Eye

  • 9.   Non Invasive Glucose Monitor Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •        1. Intensive Insulin Therapy
             2. Hypoglycemia
             3. Diabetic Foot Ulcer Tracking

  • 10.   Non Invasive Glucose Monitor Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •        1. Home Healthcare Setting
             2. Healthcare Provider
             3. Research Institutes

  • 11.   North America Non Invasive Glucose Monitor Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
              2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Non Invasive Glucose Monitor Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Non Invasive Glucose Monitor Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Non Invasive Glucose Monitor Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Non Invasive Glucose Monitor Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Google
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott Diabetes Care
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medtronic
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Apple
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Alertgy
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Integrity Applications
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Senseonics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. NovioSense BV
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Nemaura Medical
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. GENEXO
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Ambrosia Systems Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Glucology
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Sano Intelligence
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Biolinq
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Echo Therapeutics
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients